期刊文献+

X连锁显性低血磷性佝偻病并发甲状旁腺功能亢进症 被引量:2

Hyperparathyroidism in X-linked hypophosphatemia
下载PDF
导出
摘要 X连锁显性低血磷性佝偻病/骨软化症患者常并发甲状旁腺素升高,一部分与中性磷治疗相关,一部分未治疗患者即可发现继发性甲状旁腺功能亢进症,甲状旁腺素升高可进一步加重肾脏失磷,甚至引起高血压、心脏钙化等问题,增加治疗难度,影响患者生存质量,进展为三发性甲旁亢时则使治疗变得更为复杂,因此纠正或预防甲状旁腺功能亢进是X连锁显性遗传低血磷性佝偻病慢性病治疗和管理的重要部分。本文对这一并发症的临床特征、可能机制及治疗进行综述。 Hyperparathyroidism was frequently reported in patients diagnosised with X-linked Hypophosphate-mia,some of which is related to the treatment of oral phosphorus,whereas some of the untreated patients can also be complicated by this condition.Increasing parathyroid hormone can further aggravate renal phosphate wasting and is related to hypertension,cardiac calcification and so on.This complication not only increase the difficulty of treatment,but also affect the quality of life,especially when progressing to the teritary hyperparathyroidism.The management of parathyroid hormone is an important part of XLH treatment.This article reviews the clinical features,possible mechanisms,and treatment of this comorbidity.
作者 金晨曦 夏维波 JIN Chen-xi;XIA Wei-bo(Department of Endocrinology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Key Laboratory of Endocrinology of National Health Commission of the People's Republic of China,Beijing 100730,China)
机构地区 中国医学科学院
出处 《中华骨质疏松和骨矿盐疾病杂志》 CSCD 北大核心 2020年第5期479-485,共7页 Chinese Journal Of Osteoporosis And Bone Mineral Research
基金 国家“十三五”重大新药创制专项(2019ZX09734001-002) 国家自然科学基金面上项目(81670714,81970757) 中国医学科学院医学与健康科技创新工程协同创新团队项目(2016-12M-3-003)。
关键词 X连锁显性低血磷性佝偻病/骨软化症 甲状旁腺功能亢进症 甲状旁腺素 机制 治疗 X-linked hypophosphatemia parathyroid hormone hyperparathyroidism mechanism treatment
  • 相关文献

参考文献1

二级参考文献10

  • 1Hahn TJ,Scharp CR,Halstead LR.Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets[].The Journal of Clinical Endocrinology.1975
  • 2Carpenter TO.Oncogenic osteomalacia:a complex dance of factors[].The New England Journal of Medicine.2003
  • 3Lewy JE,Cabana EC,Repetto HA,et al.Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets[].The Journal of Pediatrics.1972
  • 4Carpenter. The Journal of Clinical Endocrinology . 1994
  • 5US Alon,R Levy-Olomucki,WV Moore,J Stubbs,S Liu,LD Quarles.Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets[].Clin J Am Soc Nephrol.2008
  • 6Fleisch H.Homeostasis of inorganic phosphate[].Fundamental and clinical bone physiology.1980
  • 7Bai, X,Miao, D,Li, J,Goltzman, D,Karaplis, A.C.Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate aputative role for parathyroid hormone in renal phosphate wasting disorders[].The Journal of Endocrinology.2004
  • 8C.A. Brownstein,F. Adler,C. Nelson-Williams.A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism[].Proceedings of the National Academy of Sciences of the United States of America.2008
  • 9Walton RJ,Bijvoet OL.Nomogram for determination of renal threshold phosphate concentration[].LancetThe.1975
  • 10Portale,AA,Halloran,BP,Morris,RC.Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men[].The Journal of Clinical Investigation.1989

共引文献3

同被引文献23

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部